<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38250080</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Reduced monocyte proportions and responsiveness in convalescent COVID-19 patients.</ArticleTitle><Pagination><StartPage>1329026</StartPage><MedlinePgn>1329026</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1329026</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1329026</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The clinical manifestations of acute severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) suggest a dysregulation of the host immune response that leads to inflammation, thrombosis, and organ dysfunction. It is less clear whether these dysregulated processes persist during the convalescent phase of disease or during long COVID. We sought to examine the effects of SARS-CoV-2 infection on the proportions of classical, intermediate, and nonclassical monocytes, their activation status, and their functional properties in convalescent COVID-19 patients.</AbstractText><AbstractText Label="METHODS">Peripheral blood mononuclear cells (PBMCs) from convalescent COVID-19 patients and uninfected controls were analyzed by multiparameter flow cytometry to determine relative percentages of total monocytes and monocyte subsets. The expression of activation markers and proinflammatory cytokines in response to LPS treatment were measured by flow cytometry and ELISA, respectively.</AbstractText><AbstractText Label="RESULTS">We found that the percentage of total monocytes was decreased in convalescent COVID-19 patients compared to uninfected controls. This was due to decreased intermediate and non-classical monocytes. Classical monocytes from convalescent COVID-19 patients demonstrated a decrease in activation markers, such as CD56, in response to stimulation with bacterial lipopolysaccharide (LPS). In addition, classical monocytes from convalescent COVID-19 patients showed decreased expression of CD142 (tissue factor), which can initiate the extrinsic coagulation cascade, in response to LPS stimulation. Finally, we found that monocytes from convalescent COVID-19 patients produced less TNF-&#x3b1; and IL-6 in response to LPS stimulation, than those from uninfected controls.</AbstractText><AbstractText Label="CONCLUSION">SARS-CoV-2 infection exhibits a clear effect on the relative proportions of monocyte subsets, the activation status of classical monocytes, and proinflammatory cytokine production that persists during the convalescent phase of disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Ravkov, Williams, Elgort, Barker, Planelles, Spivak, Delgado, Lin and Hanley.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ravkov</LastName><ForeName>Eugene V</ForeName><Initials>EV</Initials><AffiliationInfo><Affiliation>ARUP Laboratories Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Elizabeth S C P</ForeName><Initials>ESCP</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elgort</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ARUP Laboratories Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barker</LastName><ForeName>Adam P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>ARUP Laboratories Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Planelles</LastName><ForeName>Vicente</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Pathology, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spivak</LastName><ForeName>Adam M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado</LastName><ForeName>Julio C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>ARUP Laboratories Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Leo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ARUP Laboratories Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanley</LastName><ForeName>Timothy M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>ARUP Laboratories Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI143567</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Nat Immunol. 2022 Feb;23(2):210-216. doi: 10.1038/s41590-021-01113-x</RefSource><PMID Version="1">35027728</PMID></CommentsCorrections><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2023 Oct 26:2023.10.25.563806. doi: 10.1101/2023.10.25.563806</RefSource><PMID Version="1">37961575</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">70</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">IL-6 69</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">TNF-&#x3b1;</Keyword><Keyword MajorTopicYN="N">monocytes</Keyword><Keyword MajorTopicYN="N">tissue factor</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>5</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38250080</ArticleId><ArticleId IdType="pmc">PMC10797708</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1329026</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harrison AG, Lin T, Wang P. Mechanisms of sars-cov-2 transmission and pathogenesis. Trends Immunol (2020) 41(12):1100&#x2013;15. doi:&#xa0;10.1016/j.it.2020.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7556779</ArticleId><ArticleId IdType="pubmed">33132005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Haagmans BL. Sars-cov-2 pathogenesis. Nat Rev Microbiol (2022) 20(5):270&#x2013;84. doi:&#xa0;10.1038/s41579-022-00713-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderbeke L, Van Mol P, Van Herck Y, De Smet F, Humblet-Baron S, Martinod K, et al. . Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of covid-19 disease severity. Nat Commun (2021) 12(1):4117. doi:&#xa0;10.1038/s41467-021-24360-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24360-w</ArticleId><ArticleId IdType="pmc">PMC8257697</ArticleId><ArticleId IdType="pubmed">34226537</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, Li B, Ma H, Wang X, Cai P, Yu Q, et al. . Single-cell analysis of two severe covid-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm. Nat Commun (2020) 11(1):3924. doi:&#xa0;10.1038/s41467-020-17834-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17834-w</ArticleId><ArticleId IdType="pmc">PMC7413381</ArticleId><ArticleId IdType="pubmed">32764665</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam S, Kothari H, Bosmann M. Tissue factor in covid-19-associated coagulopathy. Thromb Res (2022) 220:35&#x2013;47. doi:&#xa0;10.1016/j.thromres.2022.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.09.025</ArticleId><ArticleId IdType="pmc">PMC9525243</ArticleId><ArticleId IdType="pubmed">36265412</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway EM, Mackman N, Warren RQ, Wolberg AS, Mosnier LO, Campbell RA, et al. . Understanding covid-19-associated coagulopathy. Nat Rev Immunol (2022) 22(10):639&#x2013;49. doi:&#xa0;10.1038/s41577-022-00762-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00762-9</ArticleId><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Paliogiannis P, Zinellu A, Scano V, Mulas G, De Riu G, Pascale RM, et al. . Laboratory test alterations in patients with covid-19 and non covid-19 interstitial pneumonia: A preliminary report. J Infect Dev Ctries (2020) 14(7):685&#x2013;90. doi:&#xa0;10.3855/jidc.12879</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.12879</ArticleId><ArticleId IdType="pubmed">32794454</ArticleId></ArticleIdList></Reference><Reference><Citation>Neeland MR, Bannister S, Clifford V, Dohle K, Mulholland K, Sutton P, et al. . Innate cell profiles during the acute and convalescent phase of sars-cov-2 infection in children. Nat Commun (2021) 12(1):1084. doi:&#xa0;10.1038/s41467-021-21414-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21414-x</ArticleId><ArticleId IdType="pmc">PMC7889848</ArticleId><ArticleId IdType="pubmed">33597531</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Schrepping J, Reusch N, Paclik D, Bassler K, Schlickeiser S, Zhang B, et al. . Severe covid-19 is marked by a dysregulated myeloid cell compartment. Cell (2020) 182(6):1419&#x2013;40 e23. doi:&#xa0;10.1016/j.cell.2020.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk AJ, Lee MJ, Wei B, Parks B, Pi R, Martinez-Colon GJ, et al. . Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in covid-19. J Exp Med (2021) 218(8). doi:&#xa0;10.1084/jem.20210582</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210582</ArticleId><ArticleId IdType="pmc">PMC8210586</ArticleId><ArticleId IdType="pubmed">34128959</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A, Chapuis N, Dunsmore G, Goubet AG, Dubuisson A, Derosa L, et al. . Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild covid-19. Cell (2020) 182(6):1401&#x2013;18 e18. doi:&#xa0;10.1016/j.cell.2020.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Chen D, Yuan D, Lausted C, Choi J, Dai CL, et al. . Multi-omics resolves a sharp disease-state shift between mild and moderate covid-19. Cell (2020) 183(6):1479&#x2013;95 e20. doi:&#xa0;10.1016/j.cell.2020.10.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.037</ArticleId><ArticleId IdType="pmc">PMC7598382</ArticleId><ArticleId IdType="pubmed">33171100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi A, Trombetta E, Cattaneo A, Castelli V, Palomba E, Tirone M, et al. . Early phases of covid-19 are characterized by a reduction in lymphocyte populations and the presence of atypical monocytes. Front Immunol (2020) 11:560330. doi:&#xa0;10.3389/fimmu.2020.560330</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.560330</ArticleId><ArticleId IdType="pmc">PMC7756112</ArticleId><ArticleId IdType="pubmed">33362757</ArticleId></ArticleIdList></Reference><Reference><Citation>Melms JC, Biermann J, Huang H, Wang Y, Nair A, Tagore S, et al. . A molecular single-cell lung atlas of lethal covid-19. Nature (2021) 595(7865):114&#x2013;9. doi:&#xa0;10.1038/s41586-021-03569-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03569-1</ArticleId><ArticleId IdType="pmc">PMC8814825</ArticleId><ArticleId IdType="pubmed">33915568</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe A, et al. . Covid-19 tissue atlases reveal sars-cov-2 pathology and cellular targets. Nature (2021) 595(7865):107&#x2013;13. doi:&#xa0;10.1038/s41586-021-03570-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, et al. . Immunophenotyping of covid-19 and influenza highlights the role of type I interferons in development of severe covid-19. Sci Immunol (2020) 5(49). doi:&#xa0;10.1126/sciimmunol.abd1554</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd1554</ArticleId><ArticleId IdType="pmc">PMC7402635</ArticleId><ArticleId IdType="pubmed">32651212</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes AJ, Courau T, Kuhn NF, Hu KH, Ray A, Chen WS, et al. . Global absence and targeting of protective immune states in severe covid-19. Nature (2021) 591(7848):124&#x2013;30. doi:&#xa0;10.1038/s41586-021-03234-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03234-7</ArticleId><ArticleId IdType="pmc">PMC8567458</ArticleId><ArticleId IdType="pubmed">33494096</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Chen X, Dan J, Hu T, Hu Y, Liu S, et al. . Innate immune imprints in sars-cov-2 omicron variant infection convalescents. Signal Transduct Target Ther (2022) 7(1):377. doi:&#xa0;10.1038/s41392-022-01237-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01237-y</ArticleId><ArticleId IdType="pmc">PMC9666472</ArticleId><ArticleId IdType="pubmed">36379915</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajamanickam A, Kumar NP, Pandiarajan AN, Selvaraj N, Munisankar S, Renji RM, et al. . Dynamic alterations in monocyte numbers, subset frequencies and activation markers in acute and convalescent covid-19 individuals. Sci Rep (2021) 11(1):20254. doi:&#xa0;10.1038/s41598-021-99705-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-99705-y</ArticleId><ArticleId IdType="pmc">PMC8511073</ArticleId><ArticleId IdType="pubmed">34642411</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Zhang Z, Koeken V, Kumar S, Aillaud M, Tsay HC, et al. . Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in covid-19. Cell Genom (2023) 3(2):100232. doi:&#xa0;10.1016/j.xgen.2022.100232</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xgen.2022.100232</ArticleId><ArticleId IdType="pmc">PMC9715265</ArticleId><ArticleId IdType="pubmed">36474914</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Dean LS, Jiyarom B, Gangcuangco LM, Shah P, Awamura T, et al. . Elevated circulating monocytes and monocyte activation in covid-19 convalescent individuals. Front Immunol (2023) 14:1151780. doi:&#xa0;10.3389/fimmu.2023.1151780</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1151780</ArticleId><ArticleId IdType="pmc">PMC10106598</ArticleId><ArticleId IdType="pubmed">37077911</ArticleId></ArticleIdList></Reference><Reference><Citation>Theobald SJ, Simonis A, Georgomanolis T, Kreer C, Zehner M, Eisfeld HS, et al. . Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in covid-19. EMBO Mol Med (2021) 13(8):e14150. doi:&#xa0;10.15252/emmm.202114150</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114150</ArticleId><ArticleId IdType="pmc">PMC8350892</ArticleId><ArticleId IdType="pubmed">34133077</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Hemati H, Bajpai M, Yadav P, Maheshwari A, Kumar S, et al. . Sustained expression of inflammatory monocytes and activated T cells in covid-19 patients and recovered convalescent plasma donors. Immun Inflamm Dis (2021) 9(4):1279&#x2013;90. doi:&#xa0;10.1002/iid3.476</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.476</ArticleId><ArticleId IdType="pmc">PMC8427128</ArticleId><ArticleId IdType="pubmed">34363351</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. . Immune cell profiling of covid-19 patients in the recovery stage by single-cell sequencing. Cell Discov (2020) 6:31. doi:&#xa0;10.1038/s41421-020-0168-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-0168-9</ArticleId><ArticleId IdType="pmc">PMC7197635</ArticleId><ArticleId IdType="pubmed">32377375</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann AD, Weinberg SE, Swaminathan S, Chaudhuri S, Mubarak HF, Schipma MJ, et al. . Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent covid-19 patients. Clin Immunol (2023), 252:109634. doi:&#xa0;10.1016/j.clim.2023.109634</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2023.109634</ArticleId><ArticleId IdType="pmc">PMC10162478</ArticleId><ArticleId IdType="pubmed">37150240</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CF, Sabath F, Fibi-Smetana S, Sun S, Ollinger R, Noessner E, et al. . Convalescent Covid-19 Patients without Comorbidities Display Similar Immunophenotypes over Time Despite Divergent Disease Severities. Front Immunol (2021) 12:601080. doi:&#xa0;10.3389/fimmu.2021.601080</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.601080</ArticleId><ArticleId IdType="pmc">PMC8634761</ArticleId><ArticleId IdType="pubmed">34867933</ArticleId></ArticleIdList></Reference><Reference><Citation>Bumbea V, Ardelean L, Radulescu L, Damian L, Bumbea H, Dumitru I, et al. . Proinflammatory role of monocytes in sars-cov-2 infection in chronic hemodialysis patients. Front Immunol (2023) 14:1210961. doi:&#xa0;10.3389/fimmu.2023.1210961</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1210961</ArticleId><ArticleId IdType="pmc">PMC10436993</ArticleId><ArticleId IdType="pubmed">37600827</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, et al. . Long-covid in children and adolescents: A systematic review and meta-analyses. Sci Rep (2022) 12(1):9950. doi:&#xa0;10.1038/s41598-022-13495-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-covid symptoms (Post-acute covid, long covid, persistent post-covid): an integrative classification. Int J Environ Res Public Health (2021) 18(5). doi:&#xa0;10.3390/ijerph18052621</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. BMJ (2020) 370:m3489. doi:&#xa0;10.1136/bmj.m3489</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Donatelli J, Henrich TJ. Long-term immunologic effects of sars-cov-2 infection: leveraging translational research methodology to address emerging questions. Transl Res (2022) 241:1&#x2013;12. doi:&#xa0;10.1016/j.trsl.2021.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2021.11.006</ArticleId><ArticleId IdType="pmc">PMC8588584</ArticleId><ArticleId IdType="pubmed">34780969</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of covid-19. Science (2022) 375(6585):1122&#x2013;7. doi:&#xa0;10.1126/science.abm8108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, et al. . Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis (2021) 224(11):1839&#x2013;48. doi:&#xa0;10.1093/infdis/jiab490</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, et al. . The il-1beta, il-6, and tnf cytokine triad is associated with post-acute sequelae of covid-19. Cell Rep Med (2022) 3(6):100663. doi:&#xa0;10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Apostolo D, Albe A, Crevola M, Errica N, Ratano G, et al. . Determinants of long covid among adults hospitalized for sars-cov-2 infection: A prospective cohort study. Front Immunol (2022) 13:1038227. doi:&#xa0;10.3389/fimmu.2022.1038227</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1038227</ArticleId><ArticleId IdType="pmc">PMC9807078</ArticleId><ArticleId IdType="pubmed">36601115</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate sars-cov-2 infection. Nat Immunol (2022) 23(2):210&#x2013;6. doi:&#xa0;10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams ES, Martins TB, Shah KS, Hill HR, Coiras M, Spivak AM, et al. . Cytokine deficiencies in patients with long-covid. J Clin Cell Immunol (2022) 13(6). doi:&#xa0;10.35248/2155-9899.22.13.672</Citation><ArticleIdList><ArticleId IdType="doi">10.35248/2155-9899.22.13.672</ArticleId><ArticleId IdType="pmc">PMC9894377</ArticleId><ArticleId IdType="pubmed">36742994</ArticleId></ArticleIdList></Reference><Reference><Citation>Rychert J, Couturier MR, Elgort M, Lozier BK, La&#x2019;ulu S, Genzen JR, et al. . Evaluation of 3 sars-cov-2 igg antibody assays and correlation with neutralizing antibodies. J Appl Lab Med (2021) 6(3):614&#x2013;24. doi:&#xa0;10.1093/jalm/jfaa188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jalm/jfaa188</ArticleId><ArticleId IdType="pmc">PMC7665531</ArticleId><ArticleId IdType="pubmed">33064790</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhen A, Krutzik SR, Levin BR, Kasparian S, Zack JA, Kitchen SG. Cd4 ligation on human blood monocytes triggers macrophage differentiation and enhances hiv infection. J Virol (2014) 88(17):9934&#x2013;46. doi:&#xa0;10.1128/JVI.00616-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00616-14</ArticleId><ArticleId IdType="pmc">PMC4136363</ArticleId><ArticleId IdType="pubmed">24942581</ArticleId></ArticleIdList></Reference><Reference><Citation>Neate EV, Greenhalgh AM, McPhee DA, Crowe SM. Bacterial lipopolysaccharide mediates the loss of cd4 from the surface of purified peripheral blood monocytes. Clin Exp Immunol (1992) 90(3):539&#x2013;44. doi:&#xa0;10.1111/j.1365-2249.1992.tb05879.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.1992.tb05879.x</ArticleId><ArticleId IdType="pmc">PMC1554593</ArticleId><ArticleId IdType="pubmed">1458690</ArticleId></ArticleIdList></Reference><Reference><Citation>Herbein G, Doyle AG, Montaner LJ, Gordon S. Lipopolysaccharide (Lps) down-regulates cd4 expression in primary human macrophages through induction of endogenous tumour necrosis factor (Tnf) and il-1 beta. Clin Exp Immunol (1995) 102(2):430&#x2013;7. doi:&#xa0;10.1111/j.1365-2249.1995.tb03801.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.1995.tb03801.x</ArticleId><ArticleId IdType="pmc">PMC1553416</ArticleId><ArticleId IdType="pubmed">7586702</ArticleId></ArticleIdList></Reference><Reference><Citation>Sconocchia G, Keyvanfar K, El Ouriaghli F, Grube M, Rezvani K, Fujiwara H, et al. . Phenotype and function of a cd56+ Peripheral blood monocyte. Leukemia (2005) 19(1):69&#x2013;76. doi:&#xa0;10.1038/sj.leu.2403550</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.leu.2403550</ArticleId><ArticleId IdType="pubmed">15526027</ArticleId></ArticleIdList></Reference><Reference><Citation>Grip O, Bredberg A, Lindgren S, Henriksson G. Increased subpopulations of cd16(+) and cd56(+) blood monocytes in patients with active crohn&#x2019;s disease. Inflamm Bowel Dis (2007) 13(5):566&#x2013;72. doi:&#xa0;10.1002/ibd.20025</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ibd.20025</ArticleId><ArticleId IdType="pubmed">17260384</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasselt M, Baerwald C, Wagner U, Rossol M. Cd56+ Monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence. Arthritis Res Ther (2013) 15(5):R139. doi:&#xa0;10.1186/ar4321</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar4321</ArticleId><ArticleId IdType="pmc">PMC3978677</ArticleId><ArticleId IdType="pubmed">24286519</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutt TS, LaVergne SM, Webb TL, Baxter BA, Stromberg S, McFann K, et al. . Comprehensive immune profiling reveals cd56(+) monocytes and cd31(+) endothelial cells are increased in severe covid-19 disease. J Immunol (2022) 208(3):685&#x2013;96. doi:&#xa0;10.4049/jimmunol.2100830</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100830</ArticleId><ArticleId IdType="pubmed">34987111</ArticleId></ArticleIdList></Reference><Reference><Citation>Campana S, De Pasquale C, Sidoti Migliore G, Pezzino G, Cavaliere R, Venanzi Rullo E, et al. . Cutting edge: hyperinflammatory monocytes expressing cd56 abound in severe covid-19 patients. J Immunol (2022) 209(4):655&#x2013;9. doi:&#xa0;10.4049/jimmunol.2200021</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2200021</ArticleId><ArticleId IdType="pubmed">35896335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler SF, Ramsdell F, Alderson MR. The activation antigen cd69. Stem Cells (1994) 12(5):456&#x2013;65. doi:&#xa0;10.1002/stem.5530120502</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.5530120502</ArticleId><ArticleId IdType="pubmed">7804122</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosche L, Knippertz I, Konig C, Royzman D, Wild AB, Zinser E, et al. . The cd83 molecule - an important immune checkpoint. Front Immunol (2020) 11:721. doi:&#xa0;10.3389/fimmu.2020.00721</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00721</ArticleId><ArticleId IdType="pmc">PMC7181454</ArticleId><ArticleId IdType="pubmed">32362900</ArticleId></ArticleIdList></Reference><Reference><Citation>Vishnyakova P, Poltavets A, Karpulevich E, Maznina A, Vtorushina V, Mikhaleva L, et al. . The response of two polar monocyte subsets to inflammation. BioMed Pharmacother (2021) 139:111614. doi:&#xa0;10.1016/j.biopha.2021.111614</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111614</ArticleId><ArticleId IdType="pubmed">33930675</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet MJ, et al. . Lps-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol (2011) 31(5):379&#x2013;446. doi:&#xa0;10.1615/critrevimmunol.v31.i5.20</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/critrevimmunol.v31.i5.20</ArticleId><ArticleId IdType="pubmed">22142165</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrovolskaia MA, Vogel SN. Toll receptors, cd14, and macrophage activation and deactivation by lps. Microbes Infect (2002) 4(9):903&#x2013;14. doi:&#xa0;10.1016/s1286-4579(02)01613-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1286-4579(02)01613-1</ArticleId><ArticleId IdType="pubmed">12106783</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaler B, Hohensinner PJ, Krychtiuk KA, Matzneller P, Koller L, Brekalo M, et al. . Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans. Sci Rep (2016) 6:30162. doi:&#xa0;10.1038/srep30162</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep30162</ArticleId><ArticleId IdType="pmc">PMC4957086</ArticleId><ArticleId IdType="pubmed">27444882</ArticleId></ArticleIdList></Reference><Reference><Citation>Tak T, van Groenendael R, Pickkers P, Koenderman L. Monocyte subsets are differentially lost from the circulation during acute inflammation induced by human experimental endotoxemia. J Innate Immun (2017) 9(5):464&#x2013;74. doi:&#xa0;10.1159/000475665</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000475665</ArticleId><ArticleId IdType="pmc">PMC6738874</ArticleId><ArticleId IdType="pubmed">28641299</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel AA, Zhang Y, Fullerton JN, Boelen L, Rongvaux A, Maini AA, et al. . The fate and lifespan of human monocyte subsets in Steady state and systemic inflammation. J Exp Med (2017) 214(7):1913&#x2013;23. doi:&#xa0;10.1084/jem.20170355</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20170355</ArticleId><ArticleId IdType="pmc">PMC5502436</ArticleId><ArticleId IdType="pubmed">28606987</ArticleId></ArticleIdList></Reference><Reference><Citation>Funderburg NT, Mayne E, Sieg SF, Asaad R, Jiang W, Kalinowska M, et al. . Increased tissue factor expression on circulating monocytes in chronic hiv infection: relationship to in vivo coagulation and immune activation. Blood (2010) 115(2):161&#x2013;7. doi:&#xa0;10.1182/blood-2009-03-210179</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-03-210179</ArticleId><ArticleId IdType="pmc">PMC2808148</ArticleId><ArticleId IdType="pubmed">19828697</ArticleId></ArticleIdList></Reference><Reference><Citation>Schechter ME, Andrade BB, He T, Richter GH, Tosh KW, Policicchio BB, et al. . Inflammatory monocytes expressing tissue factor drive siv and hiv coagulopathy. Sci Transl Med (2017) 9(405). doi:&#xa0;10.1126/scitranslmed.aam5441</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aam5441</ArticleId><ArticleId IdType="pmc">PMC5755598</ArticleId><ArticleId IdType="pubmed">28855397</ArticleId></ArticleIdList></Reference><Reference><Citation>Hottz ED, Azevedo-Quintanilha IG, Palhinha L, Teixeira L, Barreto EA, Pao CRR, et al. . Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe covid-19. Blood (2020) 136(11):1330&#x2013;41. doi:&#xa0;10.1182/blood.2020007252</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007252</ArticleId><ArticleId IdType="pmc">PMC7483437</ArticleId><ArticleId IdType="pubmed">32678428</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrello J, Caporali E, Gauthier LG, Pianezzi E, Balbi C, Rigamonti E, et al. . Risk stratification of patients with sars-cov-2 by tissue factor expression in circulating extracellular vesicles. Vascul Pharmacol (2022) 145:106999. doi:&#xa0;10.1016/j.vph.2022.106999</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2022.106999</ArticleId><ArticleId IdType="pmc">PMC9116046</ArticleId><ArticleId IdType="pubmed">35597450</ArticleId></ArticleIdList></Reference><Reference><Citation>Holstein K, Matysiak A, Witt L, Sievers B, Beckmann L, Haddad M, et al. . Lps-induced expression and release of monocyte tissue factor in patients with haemophilia. Ann Hematol (2020) 99(7):1531&#x2013;42. doi:&#xa0;10.1007/s00277-020-04075-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04075-6</ArticleId><ArticleId IdType="pmc">PMC7316670</ArticleId><ArticleId IdType="pubmed">32430703</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoll R, Schultze JL, Schulte-Schrepping J. Monocytes and macrophages in covid-19. Front Immunol (2021) 12:720109. doi:&#xa0;10.3389/fimmu.2021.720109</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.720109</ArticleId><ArticleId IdType="pmc">PMC8335157</ArticleId><ArticleId IdType="pubmed">34367190</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant RA, Morales-Nebreda L, Markov NS, Swaminathan S, Querrey M, Guzman ER, et al. . Circuits between infected macrophages and T cells in sars-cov-2 pneumonia. Nature (2021) 590(7847):635&#x2013;41. doi:&#xa0;10.1038/s41586-020-03148-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03148-w</ArticleId><ArticleId IdType="pmc">PMC7987233</ArticleId><ArticleId IdType="pubmed">33429418</ArticleId></ArticleIdList></Reference><Reference><Citation>Torbati E, Krause KL, Ussher JE. The immune response to sars-cov-2 and variants of concern. Viruses (2021) 13(10). doi:&#xa0;10.3390/v13101911</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13101911</ArticleId><ArticleId IdType="pmc">PMC8537260</ArticleId><ArticleId IdType="pubmed">34696342</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne LG, Bouhaddou M, Reuschl AK, Zuliani-Alvarez L, Polacco B, Pelin A, et al. . Evolution of enhanced innate immune evasion by sars-cov-2. Nature (2022) 602(7897):487&#x2013;95. doi:&#xa0;10.1038/s41586-021-04352-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04352-y</ArticleId><ArticleId IdType="pmc">PMC8850198</ArticleId><ArticleId IdType="pubmed">34942634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampath P, Moideen K, Ranganathan UD, Bethunaickan R. Monocyte subsets: phenotypes and function in tuberculosis infection. Front Immunol (2018) 9:1726. doi:&#xa0;10.3389/fimmu.2018.01726</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01726</ArticleId><ArticleId IdType="pmc">PMC6077267</ArticleId><ArticleId IdType="pubmed">30105020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapellos TS, Bonaguro L, Gemund I, Reusch N, Saglam A, Hinkley ER, et al. . Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol (2019) 10:2035. doi:&#xa0;10.3389/fimmu.2019.02035</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02035</ArticleId><ArticleId IdType="pmc">PMC6728754</ArticleId><ArticleId IdType="pubmed">31543877</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler-Heitbrock L. The cd14+ Cd16+ Blood monocytes: their role in infection and inflammation. J Leukoc Biol (2007) 81(3):584&#x2013;92. doi:&#xa0;10.1189/jlb.0806510</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0806510</ArticleId><ArticleId IdType="pubmed">17135573</ArticleId></ArticleIdList></Reference><Reference><Citation>Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B, et al. . Human cd14dim monocytes patrol and sense nucleic acids and viruses via tlr7 and tlr8 receptors. Immunity (2010) 33(3):375&#x2013;86. doi:&#xa0;10.1016/j.immuni.2010.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.08.012</ArticleId><ArticleId IdType="pmc">PMC3063338</ArticleId><ArticleId IdType="pubmed">20832340</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin E, Bouchet-Delbos L, Renoult O, Louvet C, Nerriere-Daguin V, Managh AJ, et al. . Human tolerogenic dendritic cells regulate immune responses through lactate synthesis. Cell Metab (2019) 30(6):1075&#x2013;90 e8. doi:&#xa0;10.1016/j.cmet.2019.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2019.11.011</ArticleId><ArticleId IdType="pubmed">31801055</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan K, Yi Z, Geng S, Li L. Development of exhausted memory monocytes and underlying mechanisms. Front Immunol (2021) 12:778830. doi:&#xa0;10.3389/fimmu.2021.778830</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.778830</ArticleId><ArticleId IdType="pmc">PMC8583871</ArticleId><ArticleId IdType="pubmed">34777396</ArticleId></ArticleIdList></Reference><Reference><Citation>Naler LB, Hsieh YP, Geng S, Zhou Z, Li L, Lu C. Epigenomic and transcriptomic analyses reveal differences between low-grade inflammation and severe exhaustion in lps-challenged murine monocytes. Commun Biol (2022) 5(1):102. doi:&#xa0;10.1038/s42003-022-03035-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03035-2</ArticleId><ArticleId IdType="pmc">PMC8799722</ArticleId><ArticleId IdType="pubmed">35091696</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda Y, Kayama H, Jeon SG, Kusu T, Isaka Y, Rakugi H, et al. . Commensal microbiota induce lps hyporesponsiveness in colonic macrophages via the production of il-10. Int Immunol (2010) 22(12):953&#x2013;62. doi:&#xa0;10.1093/intimm/dxq449</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxq449</ArticleId><ArticleId IdType="pubmed">21051439</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake K, Webb GR, et al. . Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: A molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood (2002) 99(9):3427&#x2013;31. doi:&#xa0;10.1182/blood.v99.9.3427</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.v99.9.3427</ArticleId><ArticleId IdType="pubmed">11964313</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinner NA, MacIsaac CM, Hamilton JA, Visvanathan K. Regulation of toll-like receptor (Tlr)2 and tlr4 on cd14dimcd16+ Monocytes in response to sepsis-related antigens. Clin Exp Immunol (2005) 141(2):270&#x2013;8. doi:&#xa0;10.1111/j.1365-2249.2005.02839.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2005.02839.x</ArticleId><ArticleId IdType="pmc">PMC1809439</ArticleId><ArticleId IdType="pubmed">15996191</ArticleId></ArticleIdList></Reference><Reference><Citation>El Gazzar M, Yoza BK, Hu JY, Cousart SL, McCall CE. Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance. J Biol Chem (2007) 282(37):26857&#x2013;64. doi:&#xa0;10.1074/jbc.M704584200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M704584200</ArticleId><ArticleId IdType="pubmed">17646159</ArticleId></ArticleIdList></Reference><Reference><Citation>Freise N, Burghard A, Ortkras T, Daber N, Imam Chasan A, Jauch SL, et al. . Signaling mechanisms inducing hyporesponsiveness of phagocytes during systemic inflammation. Blood (2019) 134(2):134&#x2013;46. doi:&#xa0;10.1182/blood.2019000320</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2019000320</ArticleId><ArticleId IdType="pubmed">31076441</ArticleId></ArticleIdList></Reference><Reference><Citation>Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N. Prevalence and outcomes of co-infection and superinfection with sars-cov-2 and other pathogens: A systematic review and meta-analysis. PloS One (2021) 16(5):e0251170. doi:&#xa0;10.1371/journal.pone.0251170</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251170</ArticleId><ArticleId IdType="pmc">PMC8101968</ArticleId><ArticleId IdType="pubmed">33956882</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafran N, Shafran I, Ben-Zvi H, Sofer S, Sheena L, Krause I, et al. . Secondary bacterial infection in covid-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep (2021) 11(1):12703. doi:&#xa0;10.1038/s41598-021-92220-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92220-0</ArticleId><ArticleId IdType="pmc">PMC8209102</ArticleId><ArticleId IdType="pubmed">34135459</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AP, Williams EP, Plunkett TR, Selvaraj M, Lane LC, Zalduondo L, et al. . Time-dependent increase in susceptibility and severity of secondary bacterial infections during sars-cov-2. Front Immunol (2022) 13:894534. doi:&#xa0;10.3389/fimmu.2022.894534</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.894534</ArticleId><ArticleId IdType="pmc">PMC9134015</ArticleId><ArticleId IdType="pubmed">35634338</ArticleId></ArticleIdList></Reference><Reference><Citation>Cormican S, Griffin MD. Human monocyte subset distinctions and function: insights from gene expression analysis. Front Immunol (2020) 11:1070. doi:&#xa0;10.3389/fimmu.2020.01070</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01070</ArticleId><ArticleId IdType="pmc">PMC7287163</ArticleId><ArticleId IdType="pubmed">32582174</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson E, Reynolds G, Botting RA, Calero-Nieto FJ, Morgan MD, Tuong ZK, et al. . Single-cell multi-omics analysis of the immune response in covid-19. Nat Med (2021) 27(5):904&#x2013;16. doi:&#xa0;10.1038/s41591-021-01329-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01329-2</ArticleId><ArticleId IdType="pmc">PMC8121667</ArticleId><ArticleId IdType="pubmed">33879890</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>